Palvella Therapeutics (PVLA) Treasury Shares (2014 - 2024)
Palvella Therapeutics (PVLA) posted quarterly Treasury Shares of $15.4 million for Q3 2024, little changed quarter-over-quarter from $15.4 million in Q2 2024.
Palvella Therapeutics (PVLA) Treasury Shares (2014 - 2024) Analysis & Trends
Palvella Therapeutics (PVLA) has reported Treasury Shares for 5 consecutive years, with $15.4 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Treasury Shares changed N/A year-over-year to $15.4 million; the TTM figure through Sep 2024 stood at $15.4 million (changed N/A YoY), while the FY2023 annual figure was $15.4 million, changed 0.0% from the prior year.
- Treasury Shares held at $15.4 million in Q3 2024 per PVLA's latest filing, from $15.4 million in the prior quarter.
- Across five years, Treasury Shares topped out at $15.4 million in Q4 2022 and bottomed at $15.4 million in Q4 2022.
- Historically, Treasury Shares has averaged $15.4 million across 3 years, with a median of $15.4 million in 2022.
- On a YoY basis, Treasury Shares climbed as much as 0.0% in 2023 and fell as far as 0.0% in 2023.
- Palvella Therapeutics' Treasury Shares stood at $15.4 million in 2022, then changed by 0.0% to $15.4 million in 2023, then changed by 0.0% to $15.4 million in 2024.
- Business Quant data shows PVLA's Treasury Shares at $15.4 million in Q3 2024, $15.4 million in Q2 2024, and $15.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Palvella Therapeutics | 2.25 Bn | 1.93 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 15.36 Mn |
| Sep 30, 2024 | 15.36 Mn |
| Jun 30, 2024 | 15.36 Mn |
| Jun 30, 2024 | 15.36 Mn |
| Mar 31, 2024 | 15.36 Mn |
| Mar 31, 2024 | 15.36 Mn |
| Dec 31, 2023 | 15.36 Mn |
| Dec 31, 2023 | 15.36 Mn |
| Dec 31, 2022 | 15.36 Mn |
| Dec 31, 2022 | 15.36 Mn |
| Dec 31, 2015 | 542,360.00 |
| Dec 31, 2015 | 542,360.00 |
| Dec 31, 2014 | 542,360.00 |
| Dec 31, 2014 | 542,360.00 |